Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 19 April 2001 Intellectual property and trade South Africa Drug Companies In South Africa Capitulate Under Barrage of Public Pressure
Events | 19 April 2001 Intellectual property and trade West African Regional Conference, Yaoundé, Cameroon, 19-20 April 2001, organised by MSF
Press release | 17 April 2001 Intellectual property and trade South Africa Voices Around the World Condemn Drug Industry Hypocrisy
Press release | 11 April 2001 Intellectual property and trade Statement on the WTO / WHO on Differential Pricing & Financing of Essential Drugs
Statement | 08 April 2001 Intellectual property and trade NGO Statement to the WTO / WHO on Differential Pricing & Financing of Essential Drugs
Press release | 08 March 2001 HIV/AIDS Intellectual property and trade South Africa Drop the case! Support the struggle for medicines in South Africa
Press release | 06 March 2001 HIV/AIDS Intellectual property and trade South Africa Voices of people living with HIV to be heard by South African court: MSF welcomes judge's decision to accept amicus brief
